{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T19:09:16Z","timestamp":1773860956222,"version":"3.50.1"},"reference-count":35,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T00:00:00Z","timestamp":1628380800000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,7,12]]},"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>This paper aims to establish hospitalisation costs of mesothelioma in Italy and to evaluate hospital-related trends associated with the 1992 asbestos ban.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>This is a retrospective population-based study of Italian hospitalisations treating pleura, peritoneum and pericardium mesothelioma in the period 2001\u20132018.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Settings<\/jats:title>\n                  <jats:p>Public and private Italian hospitals reached by the Ministry of Health (coverage close to 100%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>157\u2009221 admissions with primary or contributing diagnosis of pleural, peritoneal or hearth cancer discharged from 2001 to 2018.<\/jats:p>\n                  <jats:p>Primary and secondary outcome measures: number, length and cost of hospitalisations with related percentages.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Each year, Italian hospitals treated a mesothelioma in 6025 admissions on average. Mean annual costs by site were \u20ac20 293 733, \u20ac3183\u2009632 and \u20ac40 443 for pleura, peritoneum and pericardium, respectively. Pericardial mesothelioma showed the highest cost per admission (\u20ac6117), followed by peritoneal (\u20ac4549) and pleural cases (\u20ac3809). Percentage of hospitalisation costs attributable to mesothelioma was higher when it is located in pleura (53.4%) and pericardium (51.8%) with respect to peritoneum (41.2%). Overall annual hospitalisation cost, percentages of number and length of admissions showed an inverted U-shape, with maxima (of \u20ac25 850 276, 0.064% and 0.096%, respectively) reached in 2011\u20132013. Mean age at discharge and percentages of surgery and of urgent cases increased over time.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The highest impact of mesothelioma on the National Health System was recorded 20 years after the asbestos ban (2011\u20132013). Hospitals should expect soon fewer but more severe patients needing more cares. To study the disease prevalence could help assistance planning of next decade.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-046456","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T14:06:38Z","timestamp":1628517998000},"page":"e046456","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Hospitalisation costs of malignant mesothelioma: results from the Italian hospital discharge registry (2001\u20132018)"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8907-6911","authenticated-orcid":false,"given":"Pierpaolo","family":"Ferrante","sequence":"first","affiliation":[{"name":"Occupational Medicine Department, Istituto Nazionale Assicurazione Contro gli Infortuni sul Lavoro, Roma, Lazio, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"key":"2025101810183311000_11.8.e046456.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2007.09.018"},{"key":"2025101810183311000_11.8.e046456.2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0063-2016"},{"key":"2025101810183311000_11.8.e046456.3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.21037\/atm.2017.03.96","article-title":"Malignant peritoneal mesothelioma: a review","volume":"5","author":"Kim","year":"2017","journal-title":"Ann Transl Med"},{"key":"2025101810183311000_11.8.e046456.4","first-page":"261","article-title":"Primary pericardial mesothelioma unique case and literature review","volume":"39","author":"Sardar","year":"2012","journal-title":"Tex Heart Inst J"},{"key":"2025101810183311000_11.8.e046456.5","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2010-0550-RS"},{"key":"2025101810183311000_11.8.e046456.6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/030089161209800206","article-title":"Effects of combined therapies on the survival of pleural mesothelioma patients treated in Brescia, 1982-2006","volume":"98","author":"Barbieri","year":"2012","journal-title":"Tumori"},{"key":"2025101810183311000_11.8.e046456.7","article-title":"Review: new diagnostic and therapeutic avenues for mesothelioma","volume":"28","author":"Paracha","year":"2015","journal-title":"Pak J Pharm Sci"},{"key":"2025101810183311000_11.8.e046456.8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bbrc.2018.08.193","article-title":"Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22","volume":"504","author":"Okamoto","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"2025101810183311000_11.8.e046456.9","unstructured":"World Health organization . Asbestos: elimination of asbestos-related diseases, 2014. Available: http:\/\/www.who.int\/mediacentre\/factsheets\/fs343\/en\/index.html [Accessed 12 Apr 2021]."},{"key":"2025101810183311000_11.8.e046456.10","unstructured":"Current asbestos bans. Available: http:\/\/www.ibasecretariat.org\/alpha_ban_list. php [Accessed 26 Mar 2020]."},{"key":"2025101810183311000_11.8.e046456.11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604564"},{"key":"2025101810183311000_11.8.e046456.12","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-031811-124704"},{"key":"2025101810183311000_11.8.e046456.13","unstructured":"Brownson RD , Warner KK , Rosenthal JE . Current and historical American asbestos regulations. Brownson & Ballou 2012."},{"key":"2025101810183311000_11.8.e046456.14","doi-asserted-by":"crossref","unstructured":"Virta RL . Worldwide asbestos supply and consumption trends from 1900 to 2003. U.S. Geological Survey Circular 2006;1298 https:\/\/pubs.usgs.gov\/circ\/2006\/1298\/c1298.pdf","DOI":"10.3133\/cir1298"},{"key":"2025101810183311000_11.8.e046456.15","unstructured":"US Geological Survey . Mineral commodity summaries 2020, 2020. Available: https:\/\/doi.org\/10.3133\/ mcs2020"},{"key":"2025101810183311000_11.8.e046456.16","doi-asserted-by":"publisher","DOI":"10.1179\/1077352512Z.00000000021"},{"key":"2025101810183311000_11.8.e046456.17","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.lungcan.2005.03.002","article-title":"Asbestos and mesothelioma: worldwide trends","volume":"49(Suppl 1)","author":"Kazan-Allen","year":"2005","journal-title":"Lung Cancer"},{"key":"2025101810183311000_11.8.e046456.18","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2005.064998"},{"key":"2025101810183311000_11.8.e046456.19","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph14111293","article-title":"Turkey national mesothelioma surveillance and environmental asbestos exposure control program","volume":"14","author":"Metinta\u015f","year":"2017","journal-title":"Int J Environ Res Public Health"},{"key":"2025101810183311000_11.8.e046456.20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/0019-5278.146897","article-title":"Global mesothelioma epidemic: trend and features","volume":"18","author":"Bianchi","year":"2014","journal-title":"Indian J Occup Environ Med"},{"key":"2025101810183311000_11.8.e046456.21","first-page":"336","article-title":"[National epidemiological surveillance systems of mesothelioma cases]","volume":"40","author":"Ferrante","year":"2016","journal-title":"Epidemiol Prev"},{"key":"2025101810183311000_11.8.e046456.22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/10408444.2017.1315363","article-title":"Do current OELs for silica protect from obstructive lung impairment? A critical review of epidemiological data","volume":"47","author":"Hoet","year":"2017","journal-title":"Crit Rev Toxicol"},{"key":"2025101810183311000_11.8.e046456.23","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/eurpub\/ckz003","article-title":"Asbestosis and silicosis hospitalizations in Italy (2001-2015): results from the National hospital discharge registry","volume":"29","author":"Ferrante","year":"2019","journal-title":"Eur J Public Health"},{"key":"2025101810183311000_11.8.e046456.24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00420-020-01637-z","article-title":"Costs of asbestosis and silicosis hospitalization in Italy (2001-2018) : Costs of asbestosis and silicosis hospitalization","volume":"94","author":"Ferrante","year":"2021","journal-title":"Int Arch Occup Environ Health"},{"key":"2025101810183311000_11.8.e046456.25","unstructured":"Raffaella G . Legislazione E organizzazione del servizio sanitario. Santarcangelo di Romagna: Maggioli Editore, 2016. https:\/\/www.maggiolieditore.it\/legislazione-e-organizzazione-del-servizio-sanitario-1.html"},{"key":"2025101810183311000_11.8.e046456.26","unstructured":"salute M . Rapporto annuale sull\u2019attivit di ricovero ospedaliero: Dati SDO 2018 Direzione Generale della Programmazione sanitaria Ufficio 6 Roma, 2019. Available: https:\/\/www.salute.gov.it\/portale\/documentazione\/p6_2_2_1.jsp?lingua=italiano&id=2898"},{"key":"2025101810183311000_11.8.e046456.27","doi-asserted-by":"publisher","DOI":"10.1145\/1656274.1656280"},{"key":"2025101810183311000_11.8.e046456.28","unstructured":"Ferrante P , Mastrantonio M , Uccelli R . [Pleural mesothelioma mortality in Italy: time series reconstruction (1970-2009) and comparison with incidence (2003-2008)]. Epidemiol Prev 2016.doi:10.19191\/EP16.3-4.P205.087"},{"key":"2025101810183311000_11.8.e046456.29","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17020607","article-title":"Predictions of mortality from pleural mesothelioma in Italy after the ban of asbestos use","volume":"17","author":"Oddone","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"2025101810183311000_11.8.e046456.30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/19338244.2020.1747380","article-title":"Potential years of life and productivity loss due to malignant mesothelioma in turkey","volume":"75","author":"Metintas","year":"2020","journal-title":"Arch Environ Occup Health"},{"key":"2025101810183311000_11.8.e046456.31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/ejop.ejop_41_18","article-title":"The relationship between treatment cost and prognosis of malignant pleural mesothelioma in turkey","volume":"21","author":"Guntulu","year":"2019","journal-title":"Eurasian J Pulmonol"},{"key":"2025101810183311000_11.8.e046456.32","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/cam4.1378","article-title":"Determinants of malignant pleural mesothelioma survival and burden of disease in France: a national cohort analysis","volume":"7","author":"Chouaid","year":"2018","journal-title":"Cancer Med"},{"key":"2025101810183311000_11.8.e046456.33","doi-asserted-by":"publisher","DOI":"10.1136\/oemed-2016-104173"},{"key":"2025101810183311000_11.8.e046456.34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2486\/indhealth.2016-0021","article-title":"Medical costs of asbestos-related diseases in Spain between 2004 and 2011","volume":"55","author":"Garc\u00eda-G\u00f3mez","year":"2017","journal-title":"Ind Health"},{"key":"2025101810183311000_11.8.e046456.35","doi-asserted-by":"crossref","DOI":"10.1177\/2036361319863498","article-title":"Costs of medical care for mesothelioma","volume":"11","author":"Borrelli","year":"2019","journal-title":"Rare Tumors"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-046456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:18:43Z","timestamp":1760807923000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-046456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,9]]},"published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1136\/bmjopen-2020-046456"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-046456","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8]]}}}